ArticleHuman vaccines & immunotherapeutics2022

Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives.

Dominique Guillaume et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.